Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 638,598 shares, an increase of 355.8% from the August 15th total of 140,098 shares. Based on an average daily volume of 109 shares, the days-to-cover ratio is currently 5,858.7 days.
Viva Biotech Price Performance
Shares of VBIZF stock remained flat at $0.19 on Friday. The business has a 50-day moving average of $0.17 and a 200 day moving average of $0.24. Viva Biotech has a 1 year low of $0.13 and a 1 year high of $0.20.
Viva Biotech Company Profile
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Further Reading
- Five stocks we like better than Viva Biotech
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
